Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 678.0M | 647.9M | 628.0M | 592.9M |
Cost of revenue | 156.0M | 148.5M | 141.5M | 130.2M |
Gross profit | 522.1M | 499.4M | 486.5M | 462.7M |
Operating expense | ||||
Research & development | 169.8M | 170.9M | 154.3M | 139.2M |
Selling general and admin | 377.7M | 368.3M | 362.9M | 350.5M |
Other operating expenses | — | — | — | — |
Operating income | -25.4M | -40.1M | -30.7M | -27.0M |
Non operating interest income | ||||
Income | 31.3M | 30.9M | 30.0M | 27.2M |
Expense | 2.0M | 1.4M | 3.1M | 3.6M |
Other income expense | 677K | -4.9M | -652K | -1.8M |
Pretax income | 4.6M | -16.5M | -4.4M | -5.1M |
Tax provision | 8.7M | -8.8M | 7.6M | 9.8M |
Net income | -4.1M | -7.7M | -12.1M | -14.9M |
Basic EPS | 0.0 | -0.1 | -0.1 | -0.1 |
Diluted EPS | 0.0 | -0.1 | -0.1 | -0.1 |
Basic average shares | 154.9M | 153.7M | 152.6M | 151.5M |
Diluted average shares | 154.9M | 153.7M | 152.6M | 151.5M |
EBITDA | 39.0M | 13.6M | 24.4M | 22.9M |
Net income from continuing op. | -4.1M | -7.7M | -12.1M | -14.9M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |